Journal
JOURNAL OF CONTROLLED RELEASE
Volume 344, Issue -, Pages 50-61Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2021.12.027
Keywords
mRNA; Lipid nanoparticle; Inflammation; Toxicity; Nanoparticle; Adverse effect
Funding
- NIH [HL134839, HL155106, HL138269, HL153510, HL154662, AI124429]
- BioNTech
Ask authors/readers for more resources
This study investigates the effects of nucleoside-modified RNA lipid nanoparticles (modmRNA-LNPs) on inflammation and immune response in mice. The results show that modmRNA-LNPs enhance inflammatory cytokine responses after lipopolysaccharide (LPS) immune stimulation, and macrophages play a key role in mediating this phenomenon. Additionally, pretreatment with anti-inflammatory drugs can partially alleviate the inflammatory response.
Current nucleoside-modified RNA lipid nanoparticle (modmRNA-LNP) technology has successfully paved the way for the highest clinical efficacy data from next-generation vaccinations against SARS-CoV-2 during the COVID-19 pandemic. However, such modmRNA-LNP technology has not been characterized in common pre-existing inflammatory or immune-challenged conditions, raising the risk of adverse clinical effects when administering modmRNA-LNPs in such cases. Herein, we induce an acute-inflammation model in mice with lipopolysaccharide (LPS) intratracheally (IT), 1 mg kg(-1), or intravenously (IV), 2 mg kg(-1), and then IV administer modmRNA-LNP, 0.32 mg kg (-1), after 4 h, and screen for inflammatory markers, such as pro-inflammatory cytokines. ModmRNA-LNP at this dose caused no significant elevation of cytokine levels in naive mice. In contrast, shortly after LPS immune stimulation, modmRNA-LNP enhanced inflammatory cytokine responses, Interleukin-6 (IL-6) in serum and Macrophage Inflammatory Protein 2 (MIP-2) in liver significantly. Our report identifies this phenomenon as inflammation exacerbation (IE), which was proven to be specific to the LNP, acting independent of mRNA cargo, and was demonstrated to be time-and dose-dependent. Macrophage depletion as well as TLR3 -/-and TLR4-/- knockout mouse studies revealed macrophages were the immune cells involved or responsible for IE. Finally, we show that pretreatment with anti-inflammatory drugs, such as corticosteroids, can partially alleviate IE response in mice. Our findings characterize the importance of LNP-mediated IE phenomena in gram negative bacterial inflammation, however, the generalizability of modmRNA-LNP in other forms of chronic or acute inflammatory and immune contexts needs to be addressed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available